Therapeutic area intelligence for Imaging Agent with 3 indexed intelligence signals across regulatory, clinical, competitive, and market developments.

Signals: 3
Catalysts: 0
Companies: 0

Companies

No related entities indexed yet.

Assets

DATSCAN →

ZYOGREEN →

Recent signals(3)

RegulatoryJuly 26, 2026

FDA Accepts Supplement for DATSCAN (NDA022454) by GE Healthcare

The FDA has accepted a supplemental application for DATSCAN (NDA022454) from GE Healthcare.

RegulatoryJuly 15, 2026

FDA Accepts NDA for ZYOGREEN by PROVEPHARM SAS

The FDA has accepted the New Drug Application for ZYOGREEN, an injection containing Indocyanine Green.

Regulatory

July 3, 2026

FDA Grants Supplement Approval for DATSCAN (Ioflupane I-123)

The FDA has granted supplemental approval for DATSCAN, an imaging agent containing Ioflupane I-123.

Upcoming catalysts

No catalysts indexed for this entity yet.

Indications

No related entities indexed yet.

Newsletter

Get signals before the market moves

Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.

No paywall. No spam. Unsubscribe anytime.